Quick Answer
Q32 Bio Inc. reported Total Assets of $61.78 million for fiscal year 2025.
Q32 Bio Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $61.78M | -33.1% |
| 2024 | $92.33M | +96.2% |
| 2023 | $47.06M | -79.4% |
| 2022 | $228.47M | +7.9% |
| 2021 | $211.72M | -19.7% |
| 2020 | $263.74M | -15.1% |
| 2019 | $310.57M | +19.9% |
| 2018 | $259.09M | +88.4% |
| 2017 | $137.53M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $57.78M | -44.7% | -12.6% |
| June 30, 2025 | $66.12M | -46.8% | -16.4% |
| March 31, 2025 | $79.07M | -48.1% | -14.4% |
| December 31, 2024 | $92.33M | +96.2% | -11.7% |
| September 30, 2024 | $104.54M | -25.4% | -15.8% |
| June 30, 2024 | $124.21M | -26.7% | -18.5% |
| March 31, 2024 | $152.33M | -23.0% | +223.7% |
| December 31, 2023 | $47.06M | -79.4% | -66.4% |
- Q32 Bio Inc. showed a decrease of -33.1% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Q32 Bio Inc.’s total assets has declined by 55.1% (from $137.53 million to $61.78 million).
- The most recent figure is from Q32 Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: